These conditions are associated with persistent immune activation and the production of pro-inflammatory cytokines, such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP), which exacerbate endothelial dysfunction and promote atherosclerotic plaque formation. The gene discussed is CRP; the disease is endothelial dysfunction.